Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Neonatal polycythemia and hyperviscosity

E J Werner1

  • 1Division of Pediatric Hematology/Oncology, Eastern Virginia Medical School, Norfolk, USA.

Clinics in Perinatology
|September 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

von Willebrand disease in children and adolescents.

Pediatric clinics of North America·1996
Same author

Prevalence of von Willebrand disease in children: a multiethnic study.

The Journal of pediatrics·1993
Same author

Relative value of diagnostic studies for von Willebrand disease.

The Journal of pediatrics·1992
Same author

Osteoporosis as the presenting sign of leukemic relapse in an adolescent: case report and literature review.

The Journal of adolescent health : official publication of the Society for Adolescent Medicine·1992
Same author

Immunosuppressive therapy versus bone marrow transplantation for children with aplastic anemia.

Pediatrics·1989
Same author

Inhibition of human malignant neuroblastoma cell DNA synthesis by lipoxygenase metabolites of arachidonic acid.

Cancer research·1985
Same journal

Breathing Physiology into the Art of Neonatal Respiratory Care.

Clinics in perinatology·2026
Same journal

The Science and Art of Neonatal Respiratory Care.

Clinics in perinatology·2026
Same journal

Ex Utero Artificial Womb Support: Promising Future for Extremely Preterm Infants.

Clinics in perinatology·2026
Same journal

Advances in the Use of Cell-Based Therapies for Prevention of Bronchopulmonary Dysplasia.

Clinics in perinatology·2026
Same journal

Evaluation and Management of Genetic Respiratory Disorders Presenting as Hypoxemic Respiratory Failure in the Newborn Infant.

Clinics in perinatology·2026
Same journal

Modern Surfactant Delivery Methods with a Focus on Implementation of Surfactant Administration Through Laryngeal and Supraglottic Airways.

Clinics in perinatology·2026
See all related articles

Neonatal polycythemia/hyperviscosity syndrome is common but often asymptomatic. While partial exchange transfusion can improve symptoms, it does not significantly alter long-term outcomes for affected infants.

Area of Science:

  • Neonatology
  • Pediatric Hematology

Background:

  • Neonatal polycythemia/hyperviscosity syndrome affects 1-5% of newborns.
  • Significant symptoms are often linked to predisposing factors like perinatal asphyxia, intrauterine hypoxia, or hypoglycemia.
  • Infants small for gestational age and those with maternal gestational diabetes are at increased risk.

Purpose of the Study:

  • To review the clinical presentation and management of neonatal polycythemia/hyperviscosity syndrome.
  • To evaluate the efficacy of partial exchange transfusion in improving neonatal outcomes.

Main Methods:

  • Review of existing literature on neonatal polycythemia/hyperviscosity syndrome.
  • Analysis of the effects of partial exchange transfusion on hematocrit and viscosity.
  • Assessment of symptom amelioration and long-term outcomes post-intervention.

Related Experiment Videos

Main Results:

  • Partial exchange transfusion effectively lowers hematocrit and viscosity.
  • The procedure can reverse physiological abnormalities and alleviate most symptoms.
  • Long-term outcome improvements following partial exchange transfusion have not been demonstrated.

Conclusions:

  • Partial exchange transfusion is a viable symptomatic treatment for neonatal polycythemia/hyperviscosity syndrome.
  • The lack of demonstrated long-term benefits necessitates further research into optimal management strategies.
  • Identifying and managing predisposing factors remains crucial for infant health.